The MP1-22E9 monoclonal antibody reacts with mouse granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony stimulating factor 2 (CSF2). GM-CSF is a 14 kDa monomeric hematopoietic factor secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to differentiate into granulocytes (neutrophils, eosinophils, and basophils) and monocytes. The MP1-22E9 antibody is a GM-CSF neutralizing antibody.

產(chǎn)品名稱(chēng):InVivoMab anti-mouse GM-CSF

反應(yīng)種屬:mouse

宿主來(lái)源:rat

實(shí)驗(yàn)應(yīng)用:in vivo GM-CSF neutralization, in vitro GM-CSF neutralization, Flow cytometry

同種型:IgG2a, κ

免疫原:Recombinant mouse GM-CSF

克隆性:Monoclonal

克隆號(hào):MP1-22E9

產(chǎn)品濃度:Lot specific,typically between 4-11 mg/ml

保存溫度:Undiluted at 4°C in the dark

運(yùn)輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

預(yù)期分子量:150 kDa

產(chǎn)品形式:液體

有效期:One year from the date of receipt if stored as recommended

產(chǎn)地:美國(guó)

如需購(gòu)買(mǎi)或咨詢(xún)Bioxcell公司的產(chǎn)品，請(qǐng)聯(lián)系Bioxcell*代理商欣博盛生物